Jane Street’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.6M Sell
102,800
-127,400
-55% -$64.1M 0.01% 1080
2025
Q4
$107M Buy
230,200
+31,400
+16% +$14.6M 0.02% 550
2025
Q3
$84.7M Buy
198,800
+66,200
+50% +$25.7M 0.01% 669
2025
Q2
$50.8M Buy
132,600
+19,100
+17% +$6.88M 0.01% 752
2025
Q1
$39.2M Sell
113,500
-179,000
-61% -$57.6M 0.01% 820
2024
Q4
$87.8M Buy
292,500
+155,600
+114% +$54.4M 0.02% 474
2024
Q3
$55.6M Buy
136,900
+78,800
+136% +$28.9M 0.01% 643
2024
Q2
$18.7M Sell
58,100
-112,000
-66% -$36.4M ﹤0.01% 1376
2024
Q1
$56.7M Sell
170,100
-112,100
-40% -$34.3M 0.01% 573
2023
Q4
$76.4M Sell
282,200
-151,100
-35% -$37.3M 0.02% 499
2023
Q3
$107M Buy
433,300
+30,400
+8% +$8.32M 0.03% 303
2023
Q2
$122M Buy
402,900
+222,500
+123% +$61.9M 0.04% 279
2023
Q1
$47.6M Buy
180,400
+100,700
+126% +$25.6M 0.02% 548
2022
Q4
$19.1M Sell
79,700
-50,800
-39% -$11.4M 0.01% 1050
2022
Q3
$24M Sell
130,500
-20,100
-13% -$4M 0.01% 926
2022
Q2
$25.3M Buy
150,600
+39,000
+35% +$8.38M 0.01% 943
2022
Q1
$28M Buy
111,600
+50,800
+84% +$12.8M 0.01% 1018
2021
Q4
$15.6M Buy
60,800
+1,700
+3% +$416K 0.01% 1402
2021
Q3
$14.3M Sell
59,100
-42,100
-42% -$10.3M 0.01% 1393
2021
Q2
$20.9M Buy
101,200
+22,500
+29% +$4.59M 0.01% 1046
2021
Q1
$14.8M Sell
78,700
-55,800
-41% -$9.84M 0.01% 1219
2020
Q4
$22.1M Buy
134,500
+16,600
+14% +$2.43M 0.01% 810
2020
Q3
$14.7M Buy
117,900
+26,300
+29% +$3.26M 0.01% 943
2020
Q2
$8.89M Sell
91,600
-18,900
-17% -$1.96M 0.01% 1276
2020
Q1
$9.93M Buy
110,500
+68,200
+161% +$8.83M 0.01% 780
2019
Q4
$6.25M Buy
42,300
+29,500
+230% +$3.96M 0.01% 910
2019
Q3
$1.54M Sell
12,800
-5,200
-29% -$672K ﹤0.01% 2094
2019
Q2
$2.43M Buy
18,000
+3,000
+20% +$379K ﹤0.01% 1690
2019
Q1
$1.96M Sell
15,000
-2,700
-15% -$363K ﹤0.01% 2048
2018
Q4
$2.2M Buy
17,700
+15,400
+670% +$2.07M ﹤0.01% 1618
2018
Q3
$320K Sell
2,300
-14,300
-86% -$1.78M ﹤0.01% 4139
2018
Q2
$1.7M Buy
16,600
+13,800
+493% +$1.4M ﹤0.01% 2127
2018
Q1
$272K Sell
2,800
-383,400
-99% -$37.2M ﹤0.01% 4133
2017
Q4
$33.9M Buy
386,200
+182,400
+89% +$14.7M 0.1% 178
2017
Q3
$16.2M Buy
203,800
+400
+0.2% +$32.2K 0.05% 327
2017
Q2
$17.7M Buy
203,400
+195,400
+2,443% +$16.5M 0.06% 271
2017
Q1
$712K Sell
8,000
-14,800
-65% -$1.23M ﹤0.01% 2479
2016
Q4
$1.69M Sell
22,800
-58,500
-72% -$4.38M 0.01% 1474
2016
Q3
$6.15M Buy
+81,300
New +$6.23M 0.03% 499
2016
Q2
Sell
-9,800
Closed -$765K 4271
2016
Q1
$765K Sell
9,800
-1,500
-13% -$105K ﹤0.01% 2120
2015
Q4
$764K Buy
11,300
+6,500
+135% +$453K ﹤0.01% 2027
2015
Q3
$371K Sell
4,800
-8,900
-65% -$788K ﹤0.01% 2580
2015
Q2
$1.24M Buy
+13,700
New +$1.1M 0.01% 1370

Other funds holding HCA

Jane Street's HCA Position: Q1 2026 in Review

Jane Street increased its HCA Healthcare (HCA) stake by 8.9% in Q1 2026, buying an estimated $5.91M and bringing the position to 143,150 shares worth $67.7M. The position accounts for 0.01% of the portfolio, ranked #864.

Jane Street first reported a position in HCA in Q4 2013 and has held it in 48 quarters since. The position peaked at $115M in Q2 2022. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Jane Street held 143,150 shares of HCA Healthcare worth $67.7M as of Q1 2026.
  • Jane Street bought 11,747 HCA Healthcare shares in Q1 2026, an estimated $5.91M.
  • HCA Healthcare made up 0.01% of Jane Street's portfolio in Q1 2026, its #864 holding.
  • Jane Street first reported a position in HCA Healthcare in Q4 2013 and has held it in 48 quarters since.
  • Jane Street's HCA Healthcare position peaked at $115M in Q2 2022.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.